Anbio Biotechnology: xbrl:EarningsPerShareBasic
| Value | {"per": "shares", "amount": 0.105, "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/988c30f8-f486-4b1d-89b2-9e160da28e7f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/988c30f8-f486-4b1d-89b2-9e160da28e7f
History
- no predecessors — first report